Clinical Trial Update: Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating post-transplantation benadamustine and cyclophosphamide in high-risk myeloid malignancies with partially mismatched don…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Atypical Chronic Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Benadamustine (benadamustine)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia | Phase 2 | Status: RECRUITING